Skip to main content
. 2020 Jul 23;8(2):e000516. doi: 10.1136/jitc-2019-000516

Figure 4.

Figure 4

HGSOC molecular subtype. Expression profiles of the four HGSOC molecular subtypes in 18 available pre-treatment biopsies. Thirty-nine percent (7/19) were categorized as highly immunoreactive (IMR; P4, P10, P33, P1, P36, P23, and P47). DIF, differentiated; HGSOC, high-grade serous ovarian cancer; IMR, immunoreactive; MES, mesenchymal; P, patient; PD, progressive disease; PRO, proliferative; PR, partialresponse; SD, stable disease.